FR2168136A1 - 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity - Google Patents

2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity

Info

Publication number
FR2168136A1
FR2168136A1 FR7201397A FR7201397A FR2168136A1 FR 2168136 A1 FR2168136 A1 FR 2168136A1 FR 7201397 A FR7201397 A FR 7201397A FR 7201397 A FR7201397 A FR 7201397A FR 2168136 A1 FR2168136 A1 FR 2168136A1
Authority
FR
France
Prior art keywords
aminobenzoyl
hydrazones
antiinflammatory
analgesic
antipyretic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7201397A
Other languages
French (fr)
Other versions
FR2168136B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferlux SA
Original Assignee
Ferlux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferlux SA filed Critical Ferlux SA
Priority to FR7201397A priority Critical patent/FR2168136A1/en
Publication of FR2168136A1 publication Critical patent/FR2168136A1/en
Application granted granted Critical
Publication of FR2168136B1 publication Critical patent/FR2168136B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cpds. of formula: where R1 is phenyl opt. substd. by >=1 alkoxy or CF3; benzyl; the gp. where n is >1 and the phenyl gp. is opt. substd. by >=1 alkoxy; benzoyl opt. substd. by >=1 alkoxy, NO2 on the phenyl ring; R2, R3 are H, halogen, alkyl, NO2; R4, R5 are H; alkyl; COOH; phenyl opt. substd. by halogen hydroxy, or by dialkylamino when R1 is not = benzyl; pyridyl.
FR7201397A 1972-01-17 1972-01-17 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity Granted FR2168136A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7201397A FR2168136A1 (en) 1972-01-17 1972-01-17 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7201397A FR2168136A1 (en) 1972-01-17 1972-01-17 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity

Publications (2)

Publication Number Publication Date
FR2168136A1 true FR2168136A1 (en) 1973-08-31
FR2168136B1 FR2168136B1 (en) 1975-08-01

Family

ID=9091992

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7201397A Granted FR2168136A1 (en) 1972-01-17 1972-01-17 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity

Country Status (1)

Country Link
FR (1) FR2168136A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006132A1 (en) * 1986-04-07 1987-10-22 The Upjohn Company Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
DE19910396A1 (en) * 1999-03-03 2000-09-07 Schering Ag New anthranilic acid amide and isatoic acid derivatives useful in treatment of angiogenic disorders, e.g. tumors, psoriasis, arthritis and arteriosclerosis, and for prevention of vascular reocclusion
WO2000053208A2 (en) * 1999-03-09 2000-09-14 Nps Allelix Corp. Small molecules having glp-2 like activity
WO2004085382A1 (en) * 2003-03-27 2004-10-07 Kirin Beer Kabushiki Kaisha Compound inhibiting in vivo phosphorus transport and medicine containing the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1337954A (en) * 1962-08-31 1963-09-20 Ciba Geigy Process for the preparation of new hydrazides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1337954A (en) * 1962-08-31 1963-09-20 Ciba Geigy Process for the preparation of new hydrazides

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006132A1 (en) * 1986-04-07 1987-10-22 The Upjohn Company Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
DE19910396A1 (en) * 1999-03-03 2000-09-07 Schering Ag New anthranilic acid amide and isatoic acid derivatives useful in treatment of angiogenic disorders, e.g. tumors, psoriasis, arthritis and arteriosclerosis, and for prevention of vascular reocclusion
DE19910396C2 (en) * 1999-03-03 2001-12-13 Schering Ag Anthranilic acid amides and their use as medicines
WO2000053208A2 (en) * 1999-03-09 2000-09-14 Nps Allelix Corp. Small molecules having glp-2 like activity
WO2000053208A3 (en) * 1999-03-09 2001-08-09 Nps Allelix Corp Small molecules having glp-2 like activity
WO2004085382A1 (en) * 2003-03-27 2004-10-07 Kirin Beer Kabushiki Kaisha Compound inhibiting in vivo phosphorus transport and medicine containing the same
JPWO2004085382A1 (en) * 2003-03-27 2006-06-29 麒麟麦酒株式会社 Compounds that inhibit in vivo phosphorus transport and pharmaceuticals comprising the same
JP2011042655A (en) * 2003-03-27 2011-03-03 Kyowa Hakko Kirin Co Ltd Compound inhibiting in vivo phosphorus transport and medicine containing the same
US8134015B2 (en) 2003-03-27 2012-03-13 Kyowa Hakko Kirin Co., Ltd. Compound inhibiting in vivo phosphorous transport and medicine containing the same
JP4926473B2 (en) * 2003-03-27 2012-05-09 協和発酵キリン株式会社 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND PHARMACEUTICAL COMPRISING THE SAME
US20120115851A1 (en) * 2003-03-27 2012-05-10 Kyowa Hakko Kirin Co., Ltd. Compound inhibiting in vivo phosphorus transport and medicine containing the same

Also Published As

Publication number Publication date
FR2168136B1 (en) 1975-08-01

Similar Documents

Publication Publication Date Title
FR2168136A1 (en) 2-aminobenzoyl hydrazones - with antiinflammatory, analgesic and antipyretic activity
FR2155856A1 (en) N-2 pyridylureas - with antiinflammatory and analgesic activity
FR2047882A1 (en) Analgesic antiinflammatory 4-(2-alkoxy - phenylamino-quinolines and intermediates
ES418857A1 (en) Sulfur-containing ring compounds
FR2236862A1 (en) 2-Anilino-nicotinic acids - as analgesic antiinflammatory and antipyretic agents
FR2145691A1 (en) 4-hydroxy-1-benzothiopyran-3-carboxamide-s-dioxides - - as antiinflammatories
BE799291A (en) 3-Amino-2-amino methyl-2-cyclohexen-1-ones - with analgesic antipyretic, CNS depressant activity
FR2150590A1 (en) N (2-phenyl-3-pyridayon-4-yl)piperalines - with analgesic antipyretic antiinflammatory and hypotensive activity
FR2152345A1 (en) Alpha-(2-thiazolyl)oxyalkanoic acids and derivatives - - with analgesic,antiinflammatory and antipyretic activity
FR2073286A1 (en) Substd anilines - with antirheumatic analgesic and antiinflammatory activity
FR2175634A1 (en) Carboxymethoxybenzofurans derivs - analgesic antiinflammatory hypotensive activity etc
BE802453A (en) 2-Amino-5-substd-benzyl-1,3,4-thiadiazoles - pre-emergent herbicides
SU598339A1 (en) 3-Substituted Quinoxalons-2, showing analgesic activity
BG28044A3 (en) Method of obtaining of derivatives of 2- (phenylalkylhidrazono)- propionic acid
FR2146950A1 (en) 1-salicyloyl-2-quinazolines - with antiinflammatory, analgesic, antirheumatic activity
SU770025A1 (en) 2- (Carbalkoxiphenylamino) -4,6-diarylpyrimidines exhibiting analgesic activity
BG35040A3 (en) Method for preparing a benzoimic derivative of 2- (2, 6'- dichlorphenylamino)- 2- imidazoline and its salt
FR2134813A5 (en) 3-(2 phenoxy nicotinoyl)-1-phenyl-2-styryl pyrazoline-5-ones - - with antiinflammatory, analgesic, antipyretic and antirheumatic act
NL7209299A (en) Delta-4-3-oxo-11-beta-halo steroids - with hormonal activity
FR2133025A5 (en) 3-benzoyloxy-1,2-diphenylpyrazolin-5-ones - with antirheumatic and allied activities
FR2113760A1 (en) 5-Arylcarbonyl-3(or 4)-methylthien-2-yl alkanoic acids and esters - with antiinflammatory and analgesic activity
FR2088183A1 (en) Alpha-(3-pyridazon-6-yl)oxoalkanoic acids - with antiinflammatory sedative neuroleptic antihistaminic activity
FR2146952A1 (en) 4-nicotinoylamido-1-phenyl-5-pyrazolones - with antiinflammatory analgesic, antipyretic and antirheumatic activity
FR2143528A1 (en) Benzomethyl 3-phenoxynicotinates - with antiinflammatory analgesic, antipyretic, antirheumatic, tranquillizing activity
FR2168180A1 (en) Salicyclamidotetrahydrothieno pyridines - with antiinflammatory analgesic and antipyretic activity

Legal Events

Date Code Title Description
ST Notification of lapse